Truveris company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

truveris.com

Founded Year

2009

Stage

Loan | Alive

Total Raised

$57.52M

Last Raised

$3.5M | 2 yrs ago

Revenue

$0000 

About Truveris

Truveris brings transparency to the prescription drug ecosystem through data-driven innovations. Truveris' platform offers customers – from the individual patient to employers, retailers, pharmacy benefits stakeholders, and manufacturers – the data and insights they need to effectively and efficiently manage rising costs and market access challenges.

Truveris Headquarter Location

2 Park Avenue Suite 1500

New York, New York, 10016,

United States

800-430-1430

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Truveris

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Truveris is included in 5 Expert Collections, including Pharma Supply Chain.

P

Pharma Supply Chain

1,258 items

B

Biopharma Tech

5,642 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

F

Fintech

7,344 items

US-based companies

D

Digital Health

12,800 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health IT

2,231 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.

Truveris Patents

Truveris has filed 6 patents.

The 3 most popular patent topics include:

  • Pharmaceuticals policy
  • Queueing theory
  • Single queueing nodes
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/13/2017

2/8/2022

Transaction processing, Payment systems, Data management, Pharmaceuticals policy, Health economics

Grant

Application Date

3/13/2017

Grant Date

2/8/2022

Title

Related Topics

Transaction processing, Payment systems, Data management, Pharmaceuticals policy, Health economics

Status

Grant

Latest Truveris News

10:00 ET Capital Rx Appoints Healthcare Industry Veteran Kristin Begley, PharmD, as Chief Growth Officer

Feb 15, 2022

- Amid exponential growth, Capital Rx carves out new role to oversee expansion across all lines of business and market segments - A champion for healthcare price transparency and value-based care, Kristin is dedicated to providing Americans with accessible, affordable, and patient-centered care - Kristin brings two decades of healthcare leadership, business strategy, and management expertise to the company News provided by Share this article Share this article NEW YORK, Feb. 15, 2022 /PRNewswire/ --  Capital Rx , a healthtech company changing the way prescription drugs are priced and patients are serviced, today announced Kristin Begley, PharmD, has been selected as Chief Growth Officer in a newly established role. With more than two decades of financial and clinical expertise, Kristin will oversee the entire "go-to-market" organization for the company. She has a decorated career history of driving healthcare transparency and financial alignment in the pharmaceutical and healthcare industries, and most recently held leadership positions at Wildflower Health, Truveris, and Aon-Hewitt. Kristin Begley - Chief Growth Officer, Capital Rx Kristin joins Capital Rx during a period of record growth. As the fastest-growing Pharmacy Benefits Manager (PBM) in the United States, Capital Rx grew by 400% in 2020, doubled its covered lives in 2021, and expanded its customer base of employers, unions, government and healthcare entities to over 150 in the past year. Following recent legislation aimed at driving healthcare price transparency, including the 2021 Consolidated Appropriations Act, Capital Rx is uniquely qualified to completely upend the PBM market and open up the black box of prescription pricing. As the only PBM to use NADAC pricing, a government authorized benchmark used by CMS to establish significant cost savings, Capital Rx brings undistorted visibility into actual drug unit costs and eliminates arbitrary price variability. Additionally, JUDI ™, Capital Rx's enterprise healthcare platform, is opening efficiencies and capabilities never available in the pharmacy benefit management space. "I'm deeply committed to humanizing healthcare as we leverage technology to break down silos, improve interoperability, reduce costs, and improve outcomes. Pharmacy is the most accessed healthcare vertical and it has been isolated from medical for far too long. Capital Rx's platform will be foundational in next-generation care platforms," said Kristin Begley, PharmD. "It is my pleasure to work alongside the stellar team at Capital Rx as we strive to eliminate inefficient processes and financial misalignment in healthcare." Before joining Capital Rx, Kristin served as Chief Commercial Officer for Wildflower Health value-based care solution for maternal and family care for payers and providers. Previously, as Chief Pharmacy Officer at Truveris, a health technology company shining a light on the pharmaceutical supply chain black box, Kristin led the company through exponential growth. She helped build and deploy their analytical technology platform to drive efficiency in the pharmacy benefit management process for payers, advisors, and consumers. Prior, Kristin led Hewitt's National Pharmacy Practice, where she managed Rx benefit strategy for Fortune 500 companies. Earlier in her career, Kristin worked for Towers Perrin and the Managed Care Institute. "I've known Kristin for over a decade and you would be hard-pressed to find her equal," said AJ Loiacono, CEO, Capital Rx. "She will play a critical role in Capital Rx's rapid expansion into new markets, as well as continue to break down the barriers that inhibit accessible and affordable care. "  About Capital Rx Capital Rx is built around the mission of changing the way prescription drugs are priced and patients are serviced. A health technology company daring to reimagine the pharmacy benefits industry, Capital Rx is executing on that mission through its Clearinghouse Model® - the first equitable framework for drug pricing. Capital Rx's enterprise pharmacy platform, JUDI™, connects every aspect of the pharmacy ecosystem in one platform, enabling patient engagement, and increasing efficiency to achieve the highest standards of clinical care. For more information, visit  www.cap-rx.com . Media Contact:

Truveris Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Truveris Rank

  • When was Truveris founded?

    Truveris was founded in 2009.

  • Where is Truveris's headquarters?

    Truveris's headquarters is located at 2 Park Avenue, New York.

  • What is Truveris's latest funding round?

    Truveris's latest funding round is Loan.

  • How much did Truveris raise?

    Truveris raised a total of $57.52M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.